These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 17583757)
1. Squalestatin protects neurons and reduces the activation of cytoplasmic phospholipase A2 by Abeta(1-42). Bate C; Williams A Neuropharmacology; 2007 Aug; 53(2):222-31. PubMed ID: 17583757 [TBL] [Abstract][Full Text] [Related]
2. Glimepiride protects neurons against amyloid-β-induced synapse damage. Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105 [TBL] [Abstract][Full Text] [Related]
3. Ethanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage. Bate C; Williams A Neuropharmacology; 2011 Dec; 61(8):1406-12. PubMed ID: 21903110 [TBL] [Abstract][Full Text] [Related]
4. Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42. Bate C; Marshall V; Colombo L; Diomede L; Salmona M; Williams A Neuropharmacology; 2008 May; 54(6):934-43. PubMed ID: 18355880 [TBL] [Abstract][Full Text] [Related]
5. Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide. Wilson R; Bate C; Boshuizen R; Williams A; Brewer J BMC Neurosci; 2007 Nov; 8():99. PubMed ID: 18034899 [TBL] [Abstract][Full Text] [Related]
6. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration. Bate C; Williams A J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578 [TBL] [Abstract][Full Text] [Related]
7. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling. Williams RS; Bate C Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815 [TBL] [Abstract][Full Text] [Related]
8. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. Bate C; Salmona M; Diomede L; Williams A J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of statins in an in vitro model of Alzheimer's disease. Fonseca AC; Proença T; Resende R; Oliveira CR; Pereira CM J Alzheimers Dis; 2009; 17(3):503-17. PubMed ID: 19363255 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-β oligomers. McHale-Owen H; Bate C Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):649-659. PubMed ID: 29247837 [TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q10 protects against amyloid beta-induced neuronal cell death by inhibiting oxidative stress and activating the P13K pathway. Choi H; Park HH; Koh SH; Choi NY; Yu HJ; Park J; Lee YJ; Lee KY Neurotoxicology; 2012 Jan; 33(1):85-90. PubMed ID: 22186599 [TBL] [Abstract][Full Text] [Related]
12. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures. Bate C; Williams A Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738 [TBL] [Abstract][Full Text] [Related]